Has Joshua Scharf, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,251 in general payments to Joshua Scharf, MD across 183 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joshua Scharf, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joshua Scharf, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joshua Scharf, MD

Otolaryngology · Bethlehem, PANPI 1861539470

Payments from drug & device makers

$5,251in general payments, 2019–2025

Across 183 payments — averaging $28.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$1K
Inspire Medical Systems, Inc.$1K
Supernus Pharmaceuticals, Inc.$281
Optinose US, Inc.$273
Regeneron Healthcare Solutions, Inc.$202
Acclarent, Inc$173
plus $2K from 46 others

What the payments were for

Speaking & faculty fees$1002%
Travel & lodging$3787%
Food & beverage$4,77291%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	20	$1,141
Inspire Medical Systems, Inc.	24	$1,007
Supernus Pharmaceuticals, Inc.	12	$281
Optinose US, Inc.	8	$273
Regeneron Healthcare Solutions, Inc.	9	$202
Acclarent, Inc	5	$173
Sanofi	8	$172
Acera Surgical, Inc.	1	$118
Acorda Therapeutics, Inc	6	$112
GSK	5	$110
CSL Behring	4	$109
UCB, Inc.	6	$109
Teva Pharmaceuticals USA, Inc.	7	$97
Portola Pharmaceuticals, LLC	2	$71
Merz North America, Inc.	3	$67
AstraZeneca	3	$65
Alnylam Pharmaceuticals Inc.	3	$64
Adamas Pharmaceuticals, Inc.	3	$63
Tanabe Pharma America, Inc.	4	$61
Intersect ENT, Inc.	3	$55
MDD US Operations, LLC	2	$54
Neurocrine Biosciences, Inc.	2	$50
Banner Life Sciences, LLC	3	$49
EMD Serono, Inc.	2	$48
Promius Pharma LLC	3	$47
Eisai Inc.	2	$45
Pfizer	2	$43
Amgen	2	$43
Argenx US, Inc.	2	$42
Biohaven Pharmaceutical Holding Company Ltd.	2	$40
Lilly USA, LLC	2	$33
Abbott	1	$31
Vertical Pharmaceuticals, LLC	2	$30
Sumitomo Pharma America, Inc.	1	$26
Novartis	2	$24
Bausch Health US, LLC	1	$24
AbbVie	1	$24
Smith+Nephew	1	$20
KCI USA, Inc.	1	$20
Kyowa Kirin, Inc.	1	$20
Avanir Pharmaceuticals, Inc.	1	$20
Alk-abello, Inc	1	$17
Acadia Pharmaceuticals Inc	1	$17
Biohaven Pharmaceuticals, Inc.	1	$17
Bayer	1	$17
Jazz Pharmaceuticals Inc.	1	$16
Arbor Pharmaceuticals, Inc.	1	$15
Zyla Life Sciences, Inc.	1	$15
Merck	1	$14
Medtronic	1	$14
Upsher-smith Laboratories LLC	1	$14
Takeda Pharmaceuticals U.S.A., Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,251 in reported general payments places this provider in the 80th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$238,123

Medicare patients

968

Services billed

2,642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	134	$3,306
Ipratropium Bromide	87	$2,425
Fluticasone Propionate	176	$2,310
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	12	$1,400
Mometasone Furoate	20	$872
Omeprazole	54	$592
Montelukast Sodium	40	$467
Triamcinolone Acetonide	13	$368
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	21	$185
Ciprofloxacin Hcl	14	$148
Famotidine	29	$122
Prednisone	43	$110
Mupirocin	20	$94
Meclizine Hcl	13	$79
Azithromycin	11	$61

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Bethlehem

David YenBethlehem$2M
Alexander LimjucoBethlehem$15K
Nancy SnydermanPhiladelphia$4.5M
Joseph CurryPhiladelphia$2M
Stella LeePittsburgh$825K
John GermillerPhiladelphia$825K
Adam LuginbuhlPhiladelphia$745K
Neerav GoyalHershey$640K
David KennedyPhiladelphia$603K
Richard SterlingPhiladelphia$378K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →